EE200300247A - Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena - Google Patents

Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Info

Publication number: EE200300247A
Authority: EE; Estonia
Prior art keywords: isothiazole; antiproliferative agents; carboxamide salts; carboxamide; salts
Prior art date: 2000-11-28

Application number

EEP200300247A

Other languages

English (en)

Estonian (et)

Inventor

G. Gant Thomas

Robert Williams Glenn

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-28

Filing date

2001-11-19

Publication date

2003-10-15

2001-11-19 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2003-10-15 Publication of EE200300247A publication Critical patent/EE200300247A/xx

Links

BEPMYBTTZSNHPS-UHFFFAOYSA-N 1,2-thiazole-4-carboxamide Chemical class NC(=O)C=1C=NSC=1 BEPMYBTTZSNHPS-UHFFFAOYSA-N 0.000 title 1
230000001028 anti-proliverative effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Cardiology (AREA)
Oncology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

EEP200300247A 2000-11-28 2001-11-19 Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena EE200300247A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25351300P	2000-11-28	2000-11-28
PCT/IB2001/002193 WO2002044158A1 (en)	2000-11-28	2001-11-19	Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Publications (1)

Publication Number	Publication Date
EE200300247A true EE200300247A (et)	2003-10-15

Family

ID=22960587

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300247A EE200300247A (et)	2000-11-28	2001-11-19	Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Country Status (49)

Country	Link
US (1)	US6831091B2 (cs)
EP (1)	EP1337521B1 (cs)
JP (2)	JP2004514714A (cs)
KR (2)	KR20030059275A (cs)
CN (1)	CN1231474C (cs)
AP (1)	AP2001002358A0 (cs)
AR (1)	AR031512A1 (cs)
AT (1)	ATE340786T1 (cs)
AU (2)	AU2002214204B2 (cs)
BG (1)	BG107752A (cs)
BR (1)	BR0115621A (cs)
CA (1)	CA2430065C (cs)
CR (1)	CR6963A (cs)
CY (1)	CY1106240T1 (cs)
CZ (1)	CZ20031315A3 (cs)
DE (1)	DE60123461T2 (cs)
DK (1)	DK1337521T3 (cs)
DO (1)	DOP2001000288A (cs)
EA (1)	EA005859B1 (cs)
EC (1)	ECSP034628A (cs)
EE (1)	EE200300247A (cs)
ES (1)	ES2271086T3 (cs)
GE (1)	GEP20053652B (cs)
GT (1)	GT200100237A (cs)
HN (1)	HN2001000268A (cs)
HR (1)	HRP20030408A2 (cs)
HU (1)	HUP0302553A3 (cs)
IL (1)	IL155371A0 (cs)
IS (1)	IS6788A (cs)
MA (1)	MA26960A1 (cs)
MX (1)	MXPA03004714A (cs)
MY (1)	MY136686A (cs)
NO (1)	NO325187B1 (cs)
NZ (1)	NZ525788A (cs)
OA (1)	OA12532A (cs)
PA (1)	PA8533801A1 (cs)
PE (1)	PE20020591A1 (cs)
PL (1)	PL362079A1 (cs)
PT (1)	PT1337521E (cs)
SI (1)	SI1337521T1 (cs)
SK (1)	SK5862003A3 (cs)
SV (1)	SV2002000748A (cs)
TN (1)	TNSN01167A1 (cs)
TW (1)	TWI287542B (cs)
UA (1)	UA74221C2 (cs)
UY (1)	UY27039A1 (cs)
WO (1)	WO2002044158A1 (cs)
YU (1)	YU36403A (cs)
ZA (1)	ZA200303341B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA60365C2 (uk) *	1998-06-04	2003-10-15	Пфайзер Продактс Інк.	Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
US8124630B2 (en)	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en)	1999-01-13	2012-05-09	Bayer HealthCare LLC	w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en)	1999-01-13	2008-04-01	Bayer Pharmaceuticals Corporation	ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2003068229A1 (en)	2002-02-11	2003-08-21	Bayer Pharmaceuticals Corporation	Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
DK1478358T3 (da)	2002-02-11	2013-10-07	Bayer Healthcare Llc	Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
CA2493701A1 (en) *	2002-07-25	2004-02-05	Pfizer Products Inc.	Isothiazole derivatives useful as anticancer agents
EA200500234A1 (ru) *	2002-08-19	2005-08-25	Пфайзер Продактс Инк.	Комбинированная терапия гиперпролиферативных болезней
EP1636585B2 (en)	2003-05-20	2012-06-13	Bayer HealthCare LLC	Diaryl ureas with kinase inhibiting activity
PL1663978T3 (pl)	2003-07-23	2008-04-30	Bayer Healthcare Llc	Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
RU2317295C1 (ru) *	2003-10-27	2008-02-20	Мерк Энд Ко., Инк.	Соль антагониста ccr-2
US7572914B2 (en)	2003-12-19	2009-08-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
WO2005102327A1 (en) *	2004-04-20	2005-11-03	Pfizer Products Inc.	Dosage forms and methods of treatment using vegfr inhibitors
US7838524B2 (en)	2004-04-30	2010-11-23	Bayer Healthcare Llc	Substituted pyrazolyl urea derivatives useful in the treatment of cancer
TW200538104A (en) *	2004-05-17	2005-12-01	Pfizer Prod Inc	Phenyl derivatives for the treatment of abnormal cell growth
WO2006023931A2 (en)	2004-08-18	2006-03-02	Takeda San Diego, Inc.	Kinase inhibitors
EP1812439B2 (en)	2004-10-15	2017-12-06	Takeda Pharmaceutical Company Limited	Kinase inhibitors
US8119655B2 (en)	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
MY150647A (en)	2006-06-16	2014-02-14	Lundbeck & Co As H	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
US7932390B2 (en)	2006-06-29	2011-04-26	Hoffman-La Roche Inc.	Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
JP2010505962A (ja)	2006-10-09	2010-02-25	武田薬品工業株式会社	キナーゼ阻害剤
MX2010001636A (es)	2007-08-14	2010-03-15	Hoffmann La Roche	Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
WO2011073521A1 (en)	2009-12-15	2011-06-23	Petri Salven	Methods for enriching adult-derived endothelial progenitor cells and uses thereof
SG187592A1 (en)	2010-07-23	2013-03-28	Univ Boston	Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
KR102433489B1 (ko) *	2013-03-14	2022-08-17	팬옵티카, 인크.	눈의 후안부로의 약물 전달을 위한 안구용 제제
AU2015317531B2 (en) *	2014-09-17	2020-11-19	Panoptica, Inc.	Ocular formulations for drug-delivery and protection of the anterior segment of the eye
KR20250121146A (ko) *	2022-12-28	2025-08-11	비양 테라퓨틱스 컴퍼니 리미티드	단백질 티로신 키나제 억제제 및 이의 의약적 용도
WO2026002126A1 (zh) *	2024-06-27	2026-01-02	苏州必扬医药科技有限公司	一种蛋白酪氨酸激酶抑制剂及其眼用制剂
WO2026002142A1 (zh) *	2024-06-27	2026-01-02	苏州必扬医药科技有限公司	一种蛋白酪氨酸激酶抑制剂的半琥珀酸盐晶型
WO2026002133A1 (zh) *	2024-06-27	2026-01-02	苏州必扬医药科技有限公司	一种蛋白酪氨酸激酶抑制剂的盐型

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA60365C2 (uk) *	1998-06-04	2003-10-15	Пфайзер Продактс Інк.	Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця

2001
- 2001-11-19 MX MXPA03004714A patent/MXPA03004714A/es active IP Right Grant
- 2001-11-19 WO PCT/IB2001/002193 patent/WO2002044158A1/en not_active Ceased
- 2001-11-19 IL IL15537101A patent/IL155371A0/xx unknown
- 2001-11-19 EE EEP200300247A patent/EE200300247A/xx unknown
- 2001-11-19 DK DK01982663T patent/DK1337521T3/da active
- 2001-11-19 EA EA200300424A patent/EA005859B1/ru not_active IP Right Cessation
- 2001-11-19 AP APAP/P/2001/002358A patent/AP2001002358A0/en unknown
- 2001-11-19 BR BR0115621-7A patent/BR0115621A/pt not_active Application Discontinuation
- 2001-11-19 SI SI200130630T patent/SI1337521T1/sl unknown
- 2001-11-19 UA UA2003054858A patent/UA74221C2/uk unknown
- 2001-11-19 OA OA1200300137A patent/OA12532A/en unknown
- 2001-11-19 EP EP01982663A patent/EP1337521B1/en not_active Expired - Lifetime
- 2001-11-19 HR HR20030408A patent/HRP20030408A2/hr not_active Application Discontinuation
- 2001-11-19 CN CNB018193285A patent/CN1231474C/zh not_active Expired - Fee Related
- 2001-11-19 PT PT01982663T patent/PT1337521E/pt unknown
- 2001-11-19 ES ES01982663T patent/ES2271086T3/es not_active Expired - Lifetime
- 2001-11-19 GE GE5216A patent/GEP20053652B/en unknown
- 2001-11-19 AU AU2002214204A patent/AU2002214204B2/en not_active Ceased
- 2001-11-19 SK SK586-2003A patent/SK5862003A3/sk unknown
- 2001-11-19 NZ NZ525788A patent/NZ525788A/en unknown
- 2001-11-19 HU HU0302553A patent/HUP0302553A3/hu unknown
- 2001-11-19 PL PL01362079A patent/PL362079A1/xx not_active Application Discontinuation
- 2001-11-19 DO DO2001000288A patent/DOP2001000288A/es unknown
- 2001-11-19 DE DE60123461T patent/DE60123461T2/de not_active Expired - Lifetime
- 2001-11-19 AU AU1420402A patent/AU1420402A/xx active Pending
- 2001-11-19 CZ CZ20031315A patent/CZ20031315A3/cs unknown
- 2001-11-19 YU YU36403A patent/YU36403A/sh unknown
- 2001-11-19 CA CA002430065A patent/CA2430065C/en not_active Expired - Lifetime
- 2001-11-19 JP JP2002546528A patent/JP2004514714A/ja not_active Withdrawn
- 2001-11-19 AT AT01982663T patent/ATE340786T1/de not_active IP Right Cessation
- 2001-11-19 KR KR10-2003-7007057A patent/KR20030059275A/ko not_active Ceased
- 2001-11-19 KR KR1020057022534A patent/KR20050116401A/ko not_active Abandoned
- 2001-11-26 PE PE2001001179A patent/PE20020591A1/es not_active Application Discontinuation
- 2001-11-26 UY UY27039A patent/UY27039A1/es not_active Application Discontinuation
- 2001-11-26 AR ARP010105484A patent/AR031512A1/es not_active Application Discontinuation
- 2001-11-26 MY MYPI20015382A patent/MY136686A/en unknown
- 2001-11-27 TN TNTNSN01167A patent/TNSN01167A1/fr unknown
- 2001-11-27 GT GT200100237A patent/GT200100237A/es unknown
- 2001-11-27 US US09/993,640 patent/US6831091B2/en not_active Expired - Lifetime
- 2001-11-27 SV SV2001000748A patent/SV2002000748A/es unknown
- 2001-11-27 TW TW090129315A patent/TWI287542B/zh active
- 2001-11-27 PA PA20018533801A patent/PA8533801A1/es unknown
- 2001-11-27 HN HN2001000268A patent/HN2001000268A/es unknown
2003
- 2003-04-14 IS IS6788A patent/IS6788A/is unknown
- 2003-04-22 BG BG107752A patent/BG107752A/bg unknown
- 2003-04-24 CR CR6963A patent/CR6963A/es not_active Application Discontinuation
- 2003-04-30 ZA ZA200303341A patent/ZA200303341B/en unknown
- 2003-05-13 MA MA27158A patent/MA26960A1/fr unknown
- 2003-05-27 NO NO20032388A patent/NO325187B1/no unknown
- 2003-05-28 EC EC2003004628A patent/ECSP034628A/es unknown
2006
- 2006-11-13 CY CY20061101645T patent/CY1106240T1/el unknown
2007
- 2007-10-29 JP JP2007279951A patent/JP4971946B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL155371A0 (en)	2003-11-23
NZ525788A (en)	2004-11-26
YU36403A (sh)	2006-08-17
MA26960A1 (fr)	2004-12-20
DE60123461T2 (de)	2007-02-15
WO2002044158A1 (en)	2002-06-06
AR031512A1 (es)	2003-09-24
UY27039A1 (es)	2002-07-31
AU1420402A (en)	2002-06-11
HN2001000268A (es)	2002-01-30
MXPA03004714A (es)	2003-08-19
CA2430065A1 (en)	2002-06-06
EA005859B1 (ru)	2005-06-30
EP1337521B1 (en)	2006-09-27
ES2271086T3 (es)	2007-04-16
HUP0302553A2 (hu)	2003-11-28
HUP0302553A3 (en)	2009-03-30
NO20032388L (no)	2003-07-18
HK1059085A1 (en)	2004-06-18
PT1337521E (pt)	2006-12-29
AP2001002358A0 (en)	2001-12-31
PL362079A1 (en)	2004-10-18
KR20050116401A (ko)	2005-12-12
TNSN01167A1 (fr)	2005-11-10
TWI287542B (en)	2007-10-01
CY1106240T1 (el)	2011-06-08
MY136686A (en)	2008-11-28
PA8533801A1 (es)	2002-10-31
JP4971946B2 (ja)	2012-07-11
CN1231474C (zh)	2005-12-14
DK1337521T3 (da)	2007-01-29
GT200100237A (es)	2002-07-03
GEP20053652B (en)	2005-11-10
CN1476439A (zh)	2004-02-18
US20020151573A1 (en)	2002-10-17
BG107752A (bg)	2004-01-30
IS6788A (is)	2003-04-14
KR20030059275A (ko)	2003-07-07
EA200300424A1 (ru)	2003-10-30
UA74221C2 (uk)	2005-11-15
DE60123461D1 (de)	2006-11-09
SI1337521T1 (sl)	2006-12-31
BR0115621A (pt)	2003-09-02
DOP2001000288A (es)	2002-12-15
US6831091B2 (en)	2004-12-14
ATE340786T1 (de)	2006-10-15
JP2004514714A (ja)	2004-05-20
SV2002000748A (es)	2002-12-02
OA12532A (en)	2006-06-02
EP1337521A1 (en)	2003-08-27
CR6963A (es)	2003-11-25
AU2002214204B2 (en)	2007-05-24
NO325187B1 (no)	2008-02-11
CA2430065C (en)	2008-05-20
ECSP034628A (es)	2003-07-25
HRP20030408A2 (en)	2003-08-31
CZ20031315A3 (cs)	2004-04-14
NO20032388D0 (no)	2003-05-27
ZA200303341B (en)	2004-04-30
JP2008056692A (ja)	2008-03-13
PE20020591A1 (es)	2002-07-06
SK5862003A3 (en)	2004-05-04

Publication	Publication Date	Title
EE05350B1 (et)	2010-10-15	Antiproliferatiivsete vahenditena kasutatavad bensoimidasooli derivaadid
DK1122244T3 (da)	2004-10-25	Uracilforbindelser og anvendelse deraf
EE200200341A (et)	2003-10-15	Asendatud oksasolidinoonid ja nende kasutamine
DE60137897D1 (de)	2009-04-23	Absorbierender Artikel
DE60112221D1 (de)	2005-09-01	Absorbierender Artikel
DE60140977D1 (de)	2010-02-25	Absorbierender artikel
DE60104745D1 (de)	2004-09-16	Absorbierender Artikel
DE60114289D1 (de)	2005-12-01	Absorbierender Artikel
DE60108385D1 (de)	2005-02-17	Absorbierender artikel
DE60139744D1 (de)	2009-10-15	Absorbierender artikel
EE200200550A (et)	2004-02-16	Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
DE60142945D1 (de)	2010-10-14	Absorbierender Artikel
DE60117928D1 (de)	2006-05-11	Saugfähiger Artikel
ATE267178T1 (de)	2004-06-15	Diazepinderivate oder deren salze
DE60139432D1 (de)	2009-09-17	Absorbierender Artikel
DE60140838D1 (de)	2010-02-04	Saugfähiger Gegenstand
DE60139642D1 (de)	2009-10-01	Absorbierender artikel
DE60141727D1 (de)	2010-05-20	Absorbierender artikel
DE60137738D1 (de)	2009-04-09	Absorbierender Artikel
DE60111909D1 (de)	2005-08-18	Absorbierender Artikel
DE50104507D1 (de)	2010-09-16	Reinigungs- und desinfektionsmittel
NO20025510L (no)	2003-01-14	Dibenzoazulen-derivater samt anvendelse derav
DE60103683D1 (de)	2004-07-15	Wässrige Pestizidzusammensetzung
DZ3424A1 (fr)	2002-04-18	Composition pesticide
BR0113783B1 (pt)	2013-11-12	Composição aquosa